GAMA
GILD icon

Graticule Asia Macro Advisors’s Gilead Sciences GILD Stock Holding History

Graticule Asia Macro Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,700
Closed -$286K – 132
2018
Q3 		$286K Buy
+3,700
New +$279K 0.02% 207
2015
Q4 		– Sell
-37,000
Closed -$3.63M – 180
2015
Q3 		$3.63M Buy
+37,000
New +$4.11M 0.42% 40

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Graticule Asia Macro Advisors's GILD Position: Q4 2018 in Review

Graticule Asia Macro Advisors sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 3,700 shares — an estimated $286K sold.

Graticule Asia Macro Advisors first reported a position in GILD in Q3 2015 and held it in 2 quarters. The position peaked at $3.63M in Q3 2015. 1,496 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

  • Graticule Asia Macro Advisors reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
  • Graticule Asia Macro Advisors sold 3,700 Gilead Sciences shares in Q4 2018, an estimated $286K.
  • Graticule Asia Macro Advisors first reported a position in Gilead Sciences in Q3 2015 and held it in 2 quarters.
  • Graticule Asia Macro Advisors's Gilead Sciences position peaked at $3.63M in Q3 2015.
  • 1,496 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on Graticule Asia Macro Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.